HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Swearer, J. M. Articles by Lavoie, M. S. Search for Related Content PubMed PubMed Citation Articles by Swearer, J. M. Articles by Lavoie, M. S.

Predictive value of the intracarotid amobarbital test in bihemispheric seizure onset

From the Departments of Neurology (Drs. Swearer, Phillips, and Lavoie, and K.J. Kane and T.D. Anderson) and Neurosurgery (Dr. Weaver), University of Massachusetts Medical Center, Worcester, MA.

Address correspondence and reprint requests to Dr. Joan M. Swearer, Department of Neurology, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01655.

The intracarotid amobarbital test (IAT) is used to lateralize language function and assess hemispheric memory. In this study 23 nonlesional epileptic patients were evaluated. The magnitude of the difference in IAT scores between the two hemispheres was significantly greater in the patients whose seizures lateralized on scalp or intracranial EEG than in patients with bihemispheric seizure onset. This suggests that the IAT is useful not only in predicting lateralized seizure focus, but bihemispheric onset as well.

This article has been cited by other articles:

				S. A. Baxendale, P. J. Thompson, and J. S. Duncan Evidence-Based Practice: A Reevaluation of the Intracarotid Amobarbital Procedure (Wada Test) Arch Neurol, June 1, 2008; 65(6): 841 - 845. [Full Text] [PDF]